Market revenue in 2023 | USD 30.2 million |
Market revenue in 2030 | USD 61.1 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.95% in 2023. Horizon Databook has segmented the France deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Mental Health Survey by WHO, France had the highest rate of Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosis as of 2017. According to Paris Brain Institute, PD is the second cause of movement disability and affects around 8,000 people every year in France.
Furthermore, according to Fondation de France, one in five people in France is above 60 years, and by the year 2050, the number is expected to be one in three. France is estimated to have the highest incidence of suicide in the European region.
Moreover, growing number of research initiatives and increasing investments for the development of novel procedures involving deep brain stimulation devices is expected to contribute to the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account